missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ ADAM19 Polyclonal Antibody
Description
ADAM19 Polyclonal Antibody for Western Blot, IHC (P), Flow
This gene encodes a member of the ADAM (a disintegrin and metalloprotease domain) family. Members of this family are membrane-anchored proteins structurally related to snake venom disintegrins, and have been implicated in a variety of biological processes involving cell-cell and cell-matrix interactions, including fertilization, muscle development, and neurogenesis. This member is a type I transmembrane protein and serves as a marker for dendritic cell differentiation. It has also been demonstrated to be an active metalloproteinase, which may be involved in normal physiological and pathological processes such as cells migration, cell adhesion, cell-cell and cell-matrix interactions, and signal transduction.
Specifications
Specifications
| Antigen | ADAM19 |
| Applications | Flow Cytometry, Immunohistochemistry (Paraffin), Western Blot |
| Classification | Polyclonal |
| Concentration | 2 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 0.09% sodium azide; pH 7.4 |
| Gene | ADAM19 |
| Gene Accession No. | Q9H013 |
| Gene Alias | a disintegrin and metallopeptidase domain 19 (meltrin beta); a disintegrin and metalloproteinase; a disintegrin and metalloproteinase domain 19 (meltrin beta); ADAM; ADAM 19; ADAM metallopeptidase domain 19; ADAM19; ADAMs; AL024287; disintegrin and metalloproteinase domain-containing protein 19; FKSG34; MADDAM; meltrin beta; meltrin-beta; metalloendopeptidases; Metalloprotease and disintegrin dendritic antigen marker; metalloprotease-disintegrin meltrin beta; MLTNB; Sox30; SRY-box containing gene 30 |
| Gene Symbols | ADAM19 |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?